[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
June 2016

Prevalence and Predictors of Generic Drug Skepticism Among PhysiciansResults of a National Survey

Author Affiliations
  • 1Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
  • 2Harvard Medical School, Boston, Massachusetts
  • 3American Board of Internal Medicine, Philadelphia, Pennsylvania
  • 4Mongan Institute for Health Policy, Massachusetts General Hospital, Boston
JAMA Intern Med. 2016;176(6):845-847. doi:10.1001/jamainternmed.2016.1688

Generic drugs are low-cost, therapeutically equivalent versions of brand-name drugs. Use of generic drugs increases patient adherence and improves health outcomes.1 However, a 2009 survey of physicians showed that 23% disagreed that generic drugs were as effective as brand-name drugs and 50% reported quality concerns, leading more than one-quarter not to recommend generic drugs as first-line therapy.2

First Page Preview View Large
First page PDF preview
First page PDF preview